Abstract
The HIV surface glycoprotein, gp120, contains conserved and functional domains that exist within a viral envelope spike that is otherwise highly variable with respect to conformation, sequence and structure. Termed CD4-induced epitopes, these domains are stabilized on transition state gp120 structures as a consequence of CD4 receptor engagement. These nuggets of conservation naturally attract the attention of those seeking to develop vaccine and therapeutic strategies to fight infection by diverse HIV strains. However, an appreciation for the immunological relevance and practical value of CD4-induced epitopes is still evolving. This review covers the current findings related to the accessibility, antigenicity and immunogenicity of CD4-induced epitopes on gp120.
Keywords: HIV, envelope, gp120, CD4, coreceptor
Current HIV Research
Title: CD4-Induced Epitopes in the HIV Envelope Glycoprotein, Gp120
Volume: 5 Issue: 6
Author(s): Anthony L. DeVico
Affiliation:
Keywords: HIV, envelope, gp120, CD4, coreceptor
Abstract: The HIV surface glycoprotein, gp120, contains conserved and functional domains that exist within a viral envelope spike that is otherwise highly variable with respect to conformation, sequence and structure. Termed CD4-induced epitopes, these domains are stabilized on transition state gp120 structures as a consequence of CD4 receptor engagement. These nuggets of conservation naturally attract the attention of those seeking to develop vaccine and therapeutic strategies to fight infection by diverse HIV strains. However, an appreciation for the immunological relevance and practical value of CD4-induced epitopes is still evolving. This review covers the current findings related to the accessibility, antigenicity and immunogenicity of CD4-induced epitopes on gp120.
Export Options
About this article
Cite this article as:
DeVico L. Anthony, CD4-Induced Epitopes in the HIV Envelope Glycoprotein, Gp120, Current HIV Research 2007; 5 (6) . https://dx.doi.org/10.2174/157016207782418560
DOI https://dx.doi.org/10.2174/157016207782418560 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coupling of Conjugating Enzymes and Efflux Transporters: Impact on Bioavailability and Drug Interactions
Current Drug Metabolism Recent Developments in Anti-dotes Against Anthrax
Recent Patents on Anti-Infective Drug Discovery Host-Pathogen Interactions Made Transparent with the Zebrafish Model
Current Drug Targets Short Peptide Modules for Enhancing Intestinal Barrier Function
Current Pharmaceutical Design Bile Acids and Derivatives, Their Nuclear Receptors FXR, PXR and Ligands: Role in Health and Disease and Their Therapeutic Potential
Anti-Cancer Agents in Medicinal Chemistry Inhibitors of Glycine Transporter-1: Potential Therapeutics for the Treatment of CNS Disorders
Current Topics in Medicinal Chemistry HDAC Inhibitors-New Generation of Target Specific Treatment
Mini-Reviews in Medicinal Chemistry Recent Advances in Targeting Viral Proteases for the Discovery of Novel Antivirals
Current Topics in Medicinal Chemistry Potential Roles of Eosinophils in Cancer Therapy: Epidemiological Studies, Experimental Models, and Clinical Pathology
Recent Patents on Anti-Cancer Drug Discovery Targeting FLT3 Kinase in Acute Myelogenous Leukemia: Progress, Perils, and Prospects
Mini-Reviews in Medicinal Chemistry Evidence-Based Management of Infertile Couples with Repeated Implantation Failure Following IVF
Current Women`s Health Reviews Therapeutic Drug Monitoring of Busulfan in Transplantation
Current Pharmaceutical Design Mechanisms of Tubulin Binding Ligands to Target Cancer Cells: Updates on their Therapeutic Potential and Clinical Trials
Current Cancer Drug Targets Fluoride Effects: The Two Faces of Janus
Current Medicinal Chemistry Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Genetics and Biomarkers of Polyglutamine Diseases
Current Molecular Medicine From Alpha to Omega with Aβ: Targeting the Multiple Molecular Appearances of the Pathogenic Peptide in Alzheimers Disease
Current Medicinal Chemistry GABAA Receptors in Normal Development and Seizures: Friends or Foes?
Current Neuropharmacology Cognitive Dysfunction in Depression – Pathophysiology and Novel Targets
CNS & Neurological Disorders - Drug Targets